Clinical Trial Update: "As Required" Oral Sildenafil in Raynaud's Phenomenon [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 study evaluating as-needed oral sildenafil for Raynaud's Phenomenon has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Raynaud's Phenomenon | Phase 2, Phase 3 | Status: COMPLETED